Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials. ‘The company should be encouraged by the drug’s demonstrated efficacy in mild… read more.
by Bruce Sylvester – Treatment with tadalafil or sidenafil appears to improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to research published in… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be… read more.
by Bruce Sylvester – Researchers report that administering blood pressure lowering drugs to patients in the first 48 hours after a stroke does not lower the risk of… read more.
by Bruce Sylvester – Researchers report that simvastatin could become a treatment option for the secondary progressive, or chronic, stage of multiple sclerosis (MS).
by Bruce Sylvester – Following a first ischemic stroke, patients who keep their blood pressure well controlled appear to halve their risk of a second stroke, researchers reported… read more.
Little evidence other complementary or alternative therapies work. A new guideline from the American Academy of Neurology suggests that there is little evidence that most complementary or alternative… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
